Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome
about
A systematic review of global publication trends regarding long-term outcomes of ADHDEffect of treatment modality on long-term outcomes in attention-deficit/hyperactivity disorder: a systematic reviewPharmacotherapy of Attention-Deficit Hyperactivity Disorder in AdolescentsLong-Term Outcomes with Medications for Attention-Deficit Hyperactivity DisorderA systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatmentWhy the Diagnosis of Attention Deficit Hyperactivity Disorder MattersChallenges and ideas from a research program on high-quality, evidence-based practice in school mental healthSpeed and complexity characterize attention problems in children with localization-related epilepsy.Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.What influences clinicians' decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ).Two-year impact of the alternative quality contract on pediatric health care quality and spending.Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study.Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free statusUnderstanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progressParent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder.Developmental course of attention deficit hyperactivity disorder and its predictors.Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studiesRacial and ethnic disparities in ADHD diagnosis from kindergarten to eighth grade.Adherence to psychostimulant medication in children with attention-deficit/hyperactivity disorder: the role of attitudes.Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.Parental etiological explanations and longitudinal medication use for youths with attention deficit hyperactivity disorder.Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.Managing ADHD across the lifespan in the primary care setting.Psychostimulant and sensory stimulation interventions that target the reading and math deficits of students with ADHD.The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?Does long-term medication use improve the academic outcomes of youth with attention-deficit/hyperactivity disorder?Discontinuity in the transition from pediatric to adult health care for patients with attention-deficit/hyperactivity disorder.Impact of Attention-Deficit Hyperactivity Disorder on School Performance: What are the Effects of Medication?Association Between Medication Use and Performance on Higher Education Entrance Tests in Individuals With Attention-Deficit/Hyperactivity Disorder.Coaching for College Students with ADHD.Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate.A Follow-up Study of Academic Functioning and Social Adjustment in Children with Attention Deficit Hyperactivity Disorder.The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder.Assessing the toxicity and associated costs among pediatric patients admitted with unintentional poisonings of attention-deficit/hyperactivity disorder drugs in the United States.Combined Modality Intervention for ADHD With Comorbid Reading Disorders: A Proof of Concept Study.Processing Speed Mediates the Longitudinal Association between ADHD Symptoms and Preadolescent Peer Problems.Effects of methylphenidate on acute math performance in children with attention-deficit hyperactivity disorder.Effects of OROS methylphenidate on academic, behavioral, and cognitive tasks in children 9 to 12 years of age with attention-deficit/hyperactivity disorder.Executive impairment determines ADHD medication response: implications for academic achievement.Long-term outcome in ADHD and its predictors
P2860
Q21129117-CA1FC877-31DE-4340-9CBA-52B5A2CE150AQ21131827-82FE2595-C008-46A2-B066-403E57EF1169Q22241419-A4DCC45E-9195-4288-BCD3-2B54F08D7849Q22241421-E281DEC9-D198-4EF8-9B3A-401C9A90AF10Q22241759-1D12BED9-C7A5-4D50-9CD4-FB85FDFD40A2Q26774758-82245F0C-F9A0-4DA4-ADF4-332649F95924Q27022069-B402FC61-FA5D-4E72-B694-E7FB45F5A5A5Q27312356-584A3920-75C0-419C-BA9B-AFB54CA3603BQ27687469-59FB8942-D2F1-4E13-A983-3A5DFDD93EC2Q30596479-BD87E59F-5EAF-4B32-9483-77EE2242DE61Q33837036-9C14BF06-1F98-44EA-9F76-50CCF5F4F767Q34196989-2FE40B9A-EA66-406F-8679-01883C08C07DQ34472512-E5820111-C8C3-423E-88FE-151576AFAFA2Q34661181-7B5E6B41-774D-4B53-8D36-6D7514B16342Q36029110-B5DDA971-C296-48D1-AA77-E3F3F9002B59Q36591111-6ED50524-2833-4EF0-902A-2ED2C0D3DC4BQ36740926-E4365B47-0C98-40FB-9589-8BEDCCEBDD01Q36952228-C36E4F2A-54BF-484A-9707-69E479DED326Q37302020-DA44CDF8-607A-41AE-A5EA-705B10942ED9Q37348545-82E30C5A-8BCA-4632-B69F-21D869ADC08BQ37395645-4613E25F-47B2-4E92-9F98-D157DAA1F523Q37712616-4FB2928A-4DA5-468E-B2DA-FE7EEF8E9750Q37929495-10DC75E2-E71F-4C6F-88F1-36E560F04507Q37979638-55F9618D-71D1-40F9-B9A9-97F2A6E1ADE3Q37983613-123E5CC6-EFDF-4A7E-985B-B19DA99DCC28Q38017115-D5FD7134-AE26-40A6-AFD5-2CF237FCAA74Q38055292-8F68E392-A375-4479-BE1C-716D2BEB5293Q38563913-759B19DB-8BDD-4D86-80DC-3C20236213A4Q38704424-A83FC68D-7383-4D61-B2DE-5429D4131F39Q38991314-1C0C644B-EBB7-4800-AD1A-DC1D93617C77Q41436769-02273089-C81F-46FE-BE32-CE184D539C88Q42055915-91F14693-BE77-4643-9AA4-18E16288C384Q43889522-C1C4166E-94B4-44FE-85D7-05667D87168FQ46366061-EE4C8903-C9E3-4885-9064-17E967BDAE2BQ47620686-595F6F1E-7026-4699-9381-12FC57DB0985Q50317903-8C705DC7-3782-41DE-B4DC-DD28888040FEQ50675975-FFB73525-5F3F-4AB4-BE5D-0510C37A438FQ51015475-01F5871B-2519-4DF2-864A-C72CE0E9B6F6Q51017656-F8F443ED-167D-49FA-AE70-8C4522569A1FQ57738759-4C03E426-6409-405B-AABF-E44B9F51760F
P2860
Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stimulant treatment in childre ...... es adolescent academic outcome
@en
Stimulant treatment in childre ...... s adolescent academic outcome.
@nl
type
label
Stimulant treatment in childre ...... es adolescent academic outcome
@en
Stimulant treatment in childre ...... s adolescent academic outcome.
@nl
prefLabel
Stimulant treatment in childre ...... es adolescent academic outcome
@en
Stimulant treatment in childre ...... s adolescent academic outcome.
@nl
P2093
P2860
P921
P356
P1476
Stimulant treatment in childre ...... es adolescent academic outcome
@en
P2093
Carlin J Miller
Jeffrey M Halperin
Robyn L Powers
P2860
P304
P356
10.1089/CAP.2008.021
P577
2008-10-01T00:00:00Z